PEStore

Buyout PE

Whistler Capital

Whistler Capital acquires controlling stakes in established, profitable businesses, from Nashville, TN. It states a focus on healthcare & life sciences.

Disclosed holdings19
Earliest stated investment2024
HeadquartersNashville, TN
Stated fund size$2B+ regulatory assets

Stated investment criteria

What Whistler Capital says it buys

Read from Whistler Capital’s own website in August 2026. This is what the firm says it buys, not what anyone has recorded it buying, and figures are shown in the currency the firm itself used - nothing here is converted. Every line links to the page it was read from.

EBITDA it states$2m to $20m1
Transaction typesPlatform1
OfficesNashville2

A stated mandate is a firm’s description of itself and was true of the page on the day it was read; firms widen and narrow what they will look at without updating the site. Whistler Capital states that it takes majority or outright ownership. Nothing here is a commitment by Whistler Capital to consider any particular business, and nothing on this page is represented as being for sale.

Regulatory record

How Whistler Capital is registered

From this firm's Form ADV, the annual filing every registered and exempt investment adviser makes to the SEC.

Adviser statusSEC registered
Regulatory assets under management$2.5bn
Employees9
Private funds advised5 · $2.4bn gross
SEC adviser numberCRD 316528

Portfolio

Disclosed holdings

Companies Whistler Capital lists on its own website. 4 carry a stated investment year.

CompanyInvestedYears heldRecorded transaction
AmeriPro Health20242
GXP-Storage20242
Heart + Paw20242
Radiology Partners20242
ACA Group
Abridge
At Home
CHG Healthcare
ConvenientMD
Devoted Health
Embold Health
EvidenceCare
LookDeep
MultiPlan
Nest Veterinary
Sidecar Health
StoneRidge-NYDIG
Unity AI
Wellvana

Compiled from Whistler Capital’s published portfolio page. Where a recorded transaction is shown, that company was the target of a reported deal and has most likely already been realised. Nothing here is represented as being for sale.

Valuation context

Transaction values in Healthcare & Life Sciences

What companies have actually sold for in healthcare & life sciences, across 1,263 recorded transactions.

Median consideration$110m
Middle 50%$30m-$318m
Revenue multiple2.8×
EBITDA multiple12.5×

The full healthcare & life sciences picture - most active acquirers, recent transactions and every investor in the sector.

For owners

Own a healthcare & life sciences business?

The investors on this page acquire companies like yours. A confidential valuation costs nothing, commits you to nothing, and nobody is told you asked.

Request a confidential valuation

For investors

Is this Whistler Capital?

Claim this profile to correct anything wrong and tell us what you are looking for. We will send matching opportunities as they arise.

Claim or correct this profile

Targeted buyer search

Which hundred of these would actually buy your business?

A researched shortlist with a verified deal-team contact for each, and the reason it is on the list. Fixed fee, from $1,450 - or we make the approach for you and hand you the conversations.

See how it works

Comparable investors

Similar mandates

Other buyout pe investors active in healthcare & life sciences.